Dr. Rachel M. Layman MD Medical Oncologist
Dr. Rachel Layman is a medical oncologist in Columbus, Ohio. She is affiliated with multiple hospitals in the area, including James Cancer Hospital and Solove Research Institute and Ohio State University Medical Center. She received her medical degree from Case Western Reserve University School of Medicine and has been in practice for 9 years. Dr. Layman accepts several types of health insurance, listed below. She is one of 20 doctors at James Cancer Hospital and Solove Research Institute and one of 29 at Ohio State University Medical Center who specialize in Medical Oncology.
Are you Dr. Rachel Layman? Claim your profile to make edits or add details. Edit Profile
Specialty & Clinical Interests
Medical Oncologist: Breast Cancer, Cancer Genetics/Cancer Risk Assessment
James Cancer Hospital and Solove Research Institute
Ranked #20 in Cancer
Ohio State University Medical Center
Ranked #20 in Cancer
Education & Medical Training
Case Western Reserve University/University Hospitals Case Medical Center
Residency, Internal Medicine, 2001 - 2004
University of Michigan Hospitals and Health Centers
Fellowship, Hematology/Oncology, 2004 - 2008
Case Western Reserve University School of Medicine
Class of 2001
Awards, Honors & Recognition
Meaningful Use Stage 1 Certification,
Centers for Medicare & Medicaid Services
Publications & Presentations
Pilot study on the efficacy of an ondansetron- versus palonosetron-containing antiemetic regimen prior to highly emetogenic chemotherapy.
Wenzell, C. M.,Berger, M. J.,Blazer, M. A.,Crawford, B. S.,Griffith, N. L.,Wesolowski, R.,Lustberg, M. B.,Phillips, G. S.,Ramaswamy, B.,Mrozek, E.,Flynn, J. M.,Shapiro, C. L.,Layman, R. M.
Docetaxel-induced skin toxicities in breast cancer patients subsequent to paclitaxel shortage: a case series and literature review.
Poi, M. J.,Berger, M.,Lustberg, M.,Layman, R.,Shapiro, C. L.,Ramaswamy, B.,Mrozek, E.,Olson, E.,Wesolowski, R.
Severe and prolonged lymphopenia observed in patients treated with bendamustine and erlotinib for metastatic triple negative breast cancer.
Layman, R. M.,Ruppert, A. S.,Lynn, M.,Mrozek, E.,Ramaswamy, B.,Lustberg, M. B.,Wesolowski, R.,Ottman, S.,Carothers, S.,Bingman, A.,Reinbolt, R.,Kraut, E. H.,Shapiro, C. L.
- Aetna Choice POS II
- Aetna HMO
- Anthem Blue Access PPO
- Anthem Blue Preferred HMO
- BCBS Blue Card PPO
- BCBS Illinois PPO
- CIGNA HMO
- CIGNA Open Access
- CIGNA PPO
- First Choice
- First Health PPO
- Great West PPO
- Health Net Oregon PPO
- HealthAmerica HealthAssurance PPO
- Humana ChoiceCare Network PPO
- Medical Mutual of Ohio SuperMed Plus
- Medical Mutual of Ohio SuperMed POS
- Multiplan PHCS PPO
- Multiplan PPO
- ODS Network
- Premera BCBS Heritage & Heritage Plus 1
- Providence Health System Personal Option
- United Healthcare - Direct Choice Plus POS
- United Healthcare - Direct Options PPO
Help Us Keep the "U.S. News Doctor Finder" Current
If you are aware of information on this pagethat is out of date or incorrect, please let us know.
*Required Field | Your email will not be used for marketing.
Your Message Has Been Submitted
As part of our research on the correction you submitted, you may be contacted at the email address provided.
Sorry, Your Message Could Not Be Submitted
Please try again later, or E-mail your message to email@example.com and include the Web address (URL) of the page that contains incorrect information.
300 W. 10th Ave
B411 Starling Loving Hall
Columbus, OH 43210
Phone: (614) 366-8541
Fax: (614) 293-6420